Etid klinik pou Demans nan Illinois
13 etid pou Demans ap chèche patisipan nan sit nan Illinois.
Vil nan Illinois
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Great Lakes Clinical Trials - Andersonville, Chicago
- Southern Illinois University School of Medicine, Springfield
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Northwestern University, Chicago
- University of Illinois at Chicago, Chicago
- Chicago VA Medical Center/Jesse Brown VA, Chicago
- ak 4 plis
Ap rekriteFaz 4Volontè an sante akeyi
Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Re:Cognition Health - Chicago, Chicago
- Ascension Alexian Brothers, Elk Grove Village
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Medication Collaboration Feasibility Study
- Northwestern University, Chicago
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT07742189A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Insigth Hospital and Medical Center Chicago, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 90 · Tout sèks · Mizajou Jul 14, 2026 · NCT07701161A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Great Lakes Clinical Trials - Andersonville, Chicago
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582Communication Bridge 3 Study
- University of Chicago - American School Building, Chicago
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Jun 1, 2026 · NCT06191198Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Advocate Medical Group Adult Down Syndrome Center, Park Ridge
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk
- University of Chicago Medicine, Chicago
Ap rekrite
Laj 40 a 58 · Fanm · Mizajou Feb 5, 2026 · NCT06965686Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
- Loyola University, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 15, 2026 · NCT05677880Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Full List of Active Sites, Chicago
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 14, 2023 · NCT06170268Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.